- FDA Announces ADHD Drug Recall🔍
- Azurity Pharmaceuticals🔍
- ADHD medication recalled because bottles may contain completely ...🔍
- ADHD medication recalled🔍
- FDA requires updates to improve safe use of prescription stimulants🔍
- ADHD medication recalled because bottles may contain different ...🔍
- ADHD medication recalled due to labelling mishap🔍
- Mislabeled Packaging Results in Recalled ADHD Medication🔍
FDA Announces ADHD Drug Recall
FDA Announces ADHD Drug Recall | Psychiatrist.com
The FDA has announced that Azurity Pharmaceuticals Inc. issued a voluntary recall of a lot of Zenzedi CII 30 mg pills, used to treat ADHD.
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of ...
This recall has been completed and FDA has terminated this recall. · Summary · Company Announcement · Company Contact Information · Product Photos.
ADHD medication recalled because bottles may contain completely ...
The drug maker said in a recent recall notice that it is calling back one lot of Zanzedi 30 mg with lot number F230169A and an expiration date ...
ADHD medication recalled: FDA says bottles might have the wrong ...
What ADHD medication is being recalled? Azurity Pharmaceuticals is voluntarily recalling one lot of Zanzedi 30 mg with lot number F230169A. The ...
FDA requires updates to improve safe use of prescription stimulants
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. Serious risks with misuse, ...
ADHD medication recalled because bottles may contain different ...
The recalled Zenzedi medication is part of lot number F230169A and expires in June 2025, according to the recall notice. The medication was ...
ADHD medication recalled due to labelling mishap - The Independent
A drug manufacturer is voluntarily recalling one of its medications – Zenzedi – that treats ADHD and narcolepsy due to mislabeled packaging.
Mislabeled Packaging Results in Recalled ADHD Medication
On January 24, 2024, Azurity Pharmaceuticals sent an announcement to the United States FDA recalling Zenzedi, a brand name for 30 mg ...
FDA Announces ADHD Drug Recall
Azurity Pharmaceuticals Inc. issued a voluntary recall for Zenzedi CII 30 mg pills due to contamination with carbinoxamine maleate, potentially leading to under ...
ADHD medication recalled after wrong pills found in package
"Patients who take carbinoxamine instead of Zenzedi® will experience undertreatment of their symptoms, which may result in functional impairment ...
labeling updates of prescription stimulants used to treat ADHD - FDA
FDA is requiring sponsors of amphetamine and methylphenidate products medications to treat attention deficit/hyperactivity disorder (ADHD) ...
ADHD Drug Recalled; Minnesota Debates Doc-Assisted Suicide
The FDA announced a consumer-level recallopens in a new tab or window of one lot of dextroamphetamine (Zenzedi) tablets, a drug indicated for ...
FDA provides a searchable list of recalled products. Drug recalls are actions taken by a firm to remove a product from the market and may be conducted on a ...
FDA Announces Shortage of Adderall
FDA posted a shortage of the immediate release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall or ...
Safety Review Update of Medications used to treat ADHD - FDA
[11-01-2011] The U.S. Food and Drug Administration (FDA) is updating the public that a large, recently-completed study in children and young ...
Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine ...
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service.
FDA Recalls Over 7000 Bottles of Duloxetine Because of Chemical ...
The FDA announces a Class II recall for the lot #220128, which were ... https://www.fda.gov/drugs/drug-safety-and-availability ...
Akili Announces FDA Clearance of EndeavorRx™ for Children with ...
BOSTON, Mass – June 15, 2020 – Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRx™ (AKL ...
Safety Review Update of Medications used to treat Attention ... - FDA
The medications studied include stimulants (amphetamine products and methylphenidate), atomoxetine, and pemoline (no longer marketed). ADHD medications involved ...
The FDA has officially declared a shortage of Adderall - NPR
The drug, which is also known as mixed amphetamine salts, is used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. "We ...